Accelerate Diagnostics Cash Flow - Annual (NASDAQ:AXDX)

Add to My Stocks
$22.4 $0.3 (1.32%) AXDX stock closing price Sep 25, 2017 (Closing)

The cash flow statement is one of the reports a publicly traded company like Accelerate Diagnostics needs to disclose. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Accelerate Diagnostics profits and Accelerate Diagnostics debt. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Accelerate Diagnostics stock analysis. Accelerate Diagnostics generated $-53.4M cash from operating activities in 2016. Accelerate Diagnostics had an outflow of $18.28M from operating activities, $103.06M spend due to financing activities, and $46.89M spend due to investing activities for 2016. View details of Accelerate Diagnostics cash flows for latest & last 10 financial years

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec.2016201520142013201220112010200920082007
Accelerate Diagnostics Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow2.72M1.98M1.15M0.43M-0.06M0.06M0.06M0.06M0.07M
Net Increase (Decrease) in Assets Liabilities1.54M-1.36M1.25M--0.01M-0.16M0.04M-0.06M0.16M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net8.7M8.38M9.62M3.83M-0.27M-0.01M-0.14M-0.01M
Accelerate Diagnostics Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-2.4M-3.65M-1.93M-1.15M------
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-47.15M0.98M-1.43M-12.01M-----0.01M-
Other Cash Inflow (Outflow) from Investment Activities------0.08M-0.01M-0.08M-0.07M-0.11M
Accelerate Diagnostics Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares1.72M104.97M45.79M40.88M------
Issuance (Repayment) of Debt Securities-0.01M-0.14M-0.1M-------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities0.05M---------
Accelerate Diagnostics Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.12M---------
Accelerate Diagnostics Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year120.58M53.56M30.02M12.06M-0.77M0.28M0.86M1.23M1.39M
Cash & Equivalents at Year End19.24M120.58M53.56M30.02M-0.58M0.22M0.47M1.08M1.02M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Accelerate Diagnostics stock price history and Accelerate Diagnostics stock comparison chart inevitably reflect its cash flow situation.
  • Accelerate Diagnostics had a Net Change in Cash and Cash Equivalents of $-101.34M for the latest year 2016. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Accelerate Diagnostics stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Accelerate Diagnostics lost $18.28M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: Accelerate Diagnostics used $46.89M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Accelerate Diagnostics spent $103.06M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Accelerate Diagnostics Cash Flow